HCM
IRWD icon

Hodges Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Hodges Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-347,500
Closed -$1.43M – 211
2024
Q3 		$1.43M Sell
347,500
-693,500
-67% -$3.73M 0.09% 153
2024
Q2 		$6.79M Buy
1,041,000
+177,500
+21% +$1.26M 0.45% 71
2024
Q1 		$7.52M Buy
+863,500
New +$10.5M 0.48% 61
2020
Q4 		– Sell
-258,419
Closed -$2.32M – 212
2020
Q3 		$2.32M Sell
258,419
-12,894
-5% -$128K 0.45% 79
2020
Q2 		$2.8M Buy
271,313
+76,930
+40% +$787K 0.57% 67
2020
Q1 		$1.96M Sell
194,383
-98,482
-34% -$1.16M 0.5% 66
2019
Q4 		$3.9M Buy
+292,865
New +$3.23M 0.51% 64

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Hodges Capital Management's IRWD Position: Q4 2024 in Review

Hodges Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 347,500 shares — an estimated $1.43M sold.

Hodges Capital Management first reported a position in IRWD in Q4 2019 and held it in 7 quarters. The position peaked at $7.52M in Q1 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Hodges Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Hodges Capital Management sold 347,500 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $1.43M.
  • Hodges Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Hodges Capital Management's Ironwood Pharmaceuticals position peaked at $7.52M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Hodges Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.